Overview
ISO/TS 4958:2024 - Nanotechnologies - Vocabulary - Liposomes is a Technical Specification from ISO TC 229 that standardizes terminology for liposomes as lipid‑based nanomaterials in biological and biomedical contexts. The document defines core nanotechnology terms and precise vocabulary for lipid‑bilayer vesicles, their components (e.g., phospholipid, cholesterol, amphiphile), structural classes (e.g., SUV, LUV, MLV, MVL) and features such as lamellarity, bilayer thickness and phase states. It focuses on liposomes only and explicitly excludes terms unique to other lipid particle types (for example, solid lipid nanoparticles).
Key topics and technical content
- Scope and purpose: establishes consistent definitions for liposome‑related terminology used across research, regulatory and industry communications.
- Core nanotechnology terms: nanoscale, nanomaterial, nano‑object, nanostructured material, nanoparticle (references to ISO 80004 series).
- Vesicle types and size ranges: Small unilamellar vesicle (SUV, ~20–100 nm), Large unilamellar vesicle (LUV, >100 nm, typically 100–1 000 nm), multilamellar vesicle (MLV, reported about 0.5 µm–30 µm), multivesicular liposome (MVL). Typical lipid bilayer thickness is ~5 nm; therapeutic liposome diameters often fall in 50–200 nm.
- Components and regions: lipid, phospholipid, cholesterol, trapping agent, fusogen, compartments (hydrophobic vs hydrophilic regions).
- Bilayer characteristics and phases: liquid‑disordered, liquid‑ordered (cholesterol‑induced), and gel phase; lamellarity and its effect on encapsulation and release kinetics.
- Document type: vocabulary/technical specification - there are no normative references included.
Practical applications
- Ensures a common language for formulation scientists, analytical labs, toxicologists, regulators, and standards developers working with liposomal drug delivery, vaccine carriers, cosmetics and nutraceutical liposomal products.
- Supports regulatory submissions, method descriptions, product specifications and cross‑disciplinary publications by removing ambiguity about size classes, structural terms and component names.
- Helps quality control and characterization reporting by standardizing terms for lamellarity, bilayer phase and encapsulation concepts (e.g., drug loading, trapping agents).
Who should use this standard
- Pharmaceutical and biotech formulators working with lipid‑based nanocarriers
- Academic researchers in nanomedicine and drug delivery
- Regulatory authorities, product developers and contract testing laboratories
- Standards writers and technical communicators needing consistent liposome terminology
Related standards
